Friday, July 10, 2026

pharma · Weight management · Short Bowel Syndrome

Zealand Pharma

Zealand Pharma A/S is a pharma organization headquartered in EU. Primary therapeutic focus areas include Weight management, Short Bowel Syndrome, Children with congenital hyperinsulinism, Critically Ill, Mechanically Ven

Sydmarken 11, Søborg (Copenhagen), 2860, DK HQ
1998 Founded
596 Employees
EMA registrant Type
Company details
Status
Public
HQ
Sydmarken 11, Søborg (Copenhagen), 2860, DK
Founded
1998
Employees
596
Programs
18
Drugs
20
Patents
0
Clinical program

Early activity and mobilisation

Phase 3 · other · Critically Ill, Mechanically Ventilated

Early activity and mobilisation for Critically Ill, Mechanically Ventilated is a Phase 3 program (other) at Zealand Pharma A/S with 1 ClinicalTrials.gov record(s).

Internal code TEAM U1111-1195-3567

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Zealand Pharma A/S
Phase
Phase 3
Modality
other
Indication
Critically Ill, Mechanically Ventilated
Status
completed
Trials
1

Clinical trials